NEW YORK, Feb. 23, 2023 /PRNewswire/ -- The TB Alliance Board of Directors has elected David Norton as Chairperson of the Board. In this role, David will provide leadership to a diverse Board committed to advancing the vision of TB Alliance.
"David Norton has contributed greatly to TB AllianceTB Alliance's mission over his years of service as a Director," said Dr. Mel Spigelman, President and CEO of TB AllianceTB Alliance. "As he assumes this appointment to Board Chair, we look forward to benefitting from his deep commitment to our shared vision of a TB-free world. His extensive governance and leadership experience will be a huge asset in fulfilling the mission of the TB AllianceTB Alliance."
David Norton first joined TB AllianceTB Alliance's Board of Directors in 2013, bringing decades of experience in the pharmaceutical sector, with particular distinction for charting the growth of Johnson & Johnson's pharmaceuticals group. He joined TB AllianceTB Alliance's Board for the second time in 2021, having completed two terms of service from 2013-2019. In his time as a Director, he has shaped and advised TB AllianceTB Alliance's direction and contributed directly to its success.
Mr. Norton has previously served on the Board of numerous non-profit organizations and continues to serve on the Board of a number of for-profit organizations in the pharmaceutical sector, giving him a unique set of experiences and perspectives, a robust and well-rounded network, and a strong commitment to good governance—critical assets to position TB Alliance for continued success.
"The time I've spent as a member of TB Alliance's Board has been extremely exciting and rewarding," said Norton. "During that time, TB Alliance succeeded in developing and introducing a new, short, and highly effective therapy for drug-resistant TB, among other great accomplishments. I'm eager to continue to help the organization shape and achieve its strategic goals."
Mr. Norton replaces Dr. Bruce Carter, who has concluded his fourth term of service as Chair of the TB Alliance Board of Directors. An interview with Dr. Carter reflecting on his experiences in leadership at TB Alliance is featured on TB Alliance's website.
"I would also like to express my deepest gratitude for the countless contributions of Dr. Bruce Carter. Over 17 years of service on the Board, he stewarded most of our organization's strategies and activities and positioned TB Alliance as a leader in the global fight to end TB," added Dr. Spigelman.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.